K991660

Substantially Equivalent

COPALIS MULTIPLEX EBV ANTIBODY ASSAY

Applicant: DiaSorin, Inc.
Product code: LSE
Advisory panel: Microbiology
Date received: 1999-05-14
Decision date: 1999-06-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Columbia, MD, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.